Delivery Order SPE2DB22D2006-SPE2DB24FW1WF

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rinvoq ER 15 mg tablets. The award has a ceiling value of $10,943.64 and a completion date of May 29, 2024. This is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Rinvoq ER 30 mg tablets to the U.S. government. The $3,007.71 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has a completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rinvoq ER 30 mg tablets. The contract has an ultimate completion date of October 8, 2024 and a ceiling value of $6,015.42. It is a firm fixed-price contract and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,007.71 firm fixed-price delivery order is for the supply of Rinvoq ER 30 MG Tablets, which are a prescription medication. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,040.28, is for the delivery of Rinvoq ER 30 mg tablets. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Rinvoq ER 30 mg tablets. The contract has a ceiling value of $9,832.99 and an ultimate completion date of January 15, 2025. It is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen has extensive experience providing pharmaceutical products and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rinvoq ER 30 mg tablets. The $6,379.06 firm-fixed-price delivery order has an ultimate completion date of October 18, 2024. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (Corporate Office Division) for the supply of Rinvoq ER 15 mg tablets. The contract has a firm fixed price and a ceiling value of $15,956.48. The performance period extends through September 4, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $14,609.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Rinvoq ER 30 mg tablets, a medication used for various medical conditions. It has an ultimate completion date of May 21, 2024. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $53,307.37 firm fixed-price delivery order is for Rinvoq ER 15 mg tablets, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1WF
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rinvoq ER 30 mg tablets. The contract has a ceiling value of $12,030.84 and a completion date of July 15, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This federal contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products and supplies.

Generated 10/11/24, 9:11 AM